These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 620704

  • 21. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
    Toide K, Unemi N, Segawa T.
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):111-24. PubMed ID: 3925907
    [Abstract] [Full Text] [Related]

  • 22. Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels.
    Meller E, Friedhoff AJ, Friedman E.
    Life Sci; 1980 Feb 18; 26(7):541-7. PubMed ID: 7366335
    [No Abstract] [Full Text] [Related]

  • 23. [The effect of ethanol on the motor activity of rats and on the content of GABA and dopamine and its metabolites in the nigrostriatal system].
    Karpova IV.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992 Feb 18; 42(5):1027-30. PubMed ID: 1336265
    [No Abstract] [Full Text] [Related]

  • 24. Differential regulation of dopamine metabolism in solid fetal substantia nigra transplants and their terminals in the host striatum.
    Meloni R, Gale K.
    Prog Brain Res; 1990 Feb 18; 82():467-71. PubMed ID: 2127112
    [No Abstract] [Full Text] [Related]

  • 25. Dopamine release in substantia nigra?
    Korf J, Zieleman M, Westerink BH.
    Nature; 1976 Mar 18; 260(5548):257-8. PubMed ID: 1256566
    [No Abstract] [Full Text] [Related]

  • 26. Differential effects of tachykinins injected intranigrally on striatal dopamine metabolism.
    Tan DP, Tsou K.
    J Neurochem; 1988 Nov 18; 51(5):1333-7. PubMed ID: 2459306
    [Abstract] [Full Text] [Related]

  • 27. In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex: differential modulation by baclofen.
    Santiago M, Machado A, Cano J.
    Br J Pharmacol; 1993 Jul 18; 109(3):814-8. PubMed ID: 7689406
    [Abstract] [Full Text] [Related]

  • 28. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
    Koulu M, Sjöholm B, Lappalainen J, Virtanen R.
    Eur J Pharmacol; 1989 Oct 10; 169(2-3):321-4. PubMed ID: 2530097
    [Abstract] [Full Text] [Related]

  • 29. Effects of intranigral administration of dopamine agonists and antagonists and baclofen on concentrations of dopac and dopamine in the striatum and substantia nigra of the rat.
    Wuerthele SM, Friedle NM, Moore KE.
    J Neural Transm; 1979 Oct 10; 45(2):117-27. PubMed ID: 469523
    [Abstract] [Full Text] [Related]

  • 30. Neurochemical sequelae of kainate injections in corpus striatum and substantia nigra of the rat.
    Schwarcz R, Coyle JT.
    Life Sci; 1977 Feb 01; 20(3):431-6. PubMed ID: 14287
    [No Abstract] [Full Text] [Related]

  • 31. The effect of methionine-enkephalin and D-alanine methionine-enkephalinamide on the concentration of dopamine metabolites in rat striatum.
    Algeri S, Calderini G, Consolazione A, Garattini S.
    Eur J Pharmacol; 1977 Sep 15; 45(2):207-9. PubMed ID: 902691
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats.
    Kelly E, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1987 Mar 15; 39(3):196-202. PubMed ID: 2883284
    [Abstract] [Full Text] [Related]

  • 33. Intranigral injected iron progressively reduces striatal dopamine metabolism.
    Wesemann W, Blaschke S, Solbach M, Grote C, Clement HW, Riederer P.
    J Neural Transm Park Dis Dement Sect; 1994 Mar 15; 8(3):209-14. PubMed ID: 7748464
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa.
    Brannan T, Knott P, Kaufmann H, Yahr M.
    Adv Neurol; 1990 Mar 15; 53():75-81. PubMed ID: 2173378
    [No Abstract] [Full Text] [Related]

  • 36. Apomorphine increases glucose utilization in the substantia nigra, subthalamic nucleus and corpus striatum of rat.
    Brown LL, Wolfson LI.
    Brain Res; 1978 Jan 20; 140(1):188-93. PubMed ID: 626883
    [No Abstract] [Full Text] [Related]

  • 37. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H, Sundström E, Jonsson G, Hjorth S, Carlsson A.
    J Neurochem; 1989 Apr 20; 52(4):1170-82. PubMed ID: 2564423
    [Abstract] [Full Text] [Related]

  • 38. An investigation of dopaminergic metabolites in the striatum and in the substantia nigra in vivo utilising radiolabelled L-DOPA and high performance liquid chromatography: a new approach in the search for transmitter metabolites.
    Niazi Shahabi H, Bergquist F, Nissbrandt H.
    Neuroscience; 2003 Apr 20; 120(2):425-33. PubMed ID: 12890512
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.